title: Using biomaterials to improve the efficacy of cell therapy following acute myocardial infarction.
abstract: Cardiovascular cell therapy has the potential to improve left ventricular (LV) function and alter the course of adverse LV remodeling following acute myocardial infarction (AMI). However, current therapy using autologous intracoronary bone marrow mononuclear cells results in only minimal recovery of LV function. A major impediment appears to be limited retention and engraftment of the transplanted cells, in part due to loss of the extracellular matrix (ECM) following AMI that can lead to apoptosis of the delivered cells through the mechanism of anoikis. Recent pre-clinical studies suggest that the delivery of ECM surrogates to the infarct zone following AMI significantly improves LV function through multiple mechanisms. The use of ECM surrogates in conjunction with stem cell administration may represent a new paradigm for cardiac repair following AMI. This review discusses the potential use of biologically based ECM surrogates in the clinical setting following STEMI.
authors.affiliation: Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN 55407, USA. trave004@umn.edu
authors.forename: Jay H
authors.initials: JH
authors.lastname: Traverse
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D017690:Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D002478:Cells, Cultured; D005109:Extracellular Matrix / Q000378:metabolism*; D006801:Humans; D009203:Myocardial Infarction / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D020127:Recovery of Function; D012038:Regeneration; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds; D016896:Treatment Outcome; D016277:Ventricular Function, Left; D020257:Ventricular Remodeling
chemical_list: D001672:Biocompatible Materials
references.citation: J Am Coll Cardiol. 2009 Dec 8;54(24):2277-86
references.pmid: 19958962
references.citation: Circ Res. 2015 Aug 28;117(6):576-84
references.pmid: 26148930
references.citation: Cell Stem Cell. 2011 Apr 8;8(4):389-98
references.pmid: 21474103
references.citation: Am Heart J. 2011 Jun;161(6):1078-87.e3
references.pmid: 21641354
references.citation: Eur Heart J. 2008 Aug;29(15):1911-21
references.pmid: 18544545
references.citation: J Mol Cell Cardiol. 2010 Mar;48(3):504-11
references.pmid: 19631653
references.citation: J Cardiovasc Transl Res. 2010 Oct;3(5):478-86
references.pmid: 20632221
references.citation: Circulation. 2005 Feb 1;111(4):442-50
references.pmid: 15687132
references.citation: Cell Transplant. 2009;18(3):343-52
references.pmid: 19558782
references.citation: Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2146-54
references.pmid: 14551156
references.citation: Circ Res. 2004 Jun 25;94(12):1543-53
references.pmid: 15217919
references.citation: Circ Res. 2012 Jan 20;110(2):304-11
references.pmid: 22052917
references.citation: Circulation. 2008 Sep 30;118(14):1425-32
references.pmid: 18794392
references.citation: J Am Coll Cardiol. 2010 Mar 23;55(12):1250-1261
references.pmid: 20298933
references.citation: Cell Transplant. 2002;11(7):621-30
references.pmid: 12518889
references.citation: Biomaterials. 2010 Oct;31(30):7678-83
references.pmid: 20674011
references.citation: Lancet. 2003 Aug 30;362(9385):697-703
references.pmid: 12957092
references.citation: J Am Coll Cardiol. 2004 Aug 4;44(3):654-60
references.pmid: 15358036
references.citation: Circulation. 2005 May 3;111(17):2198-202
references.pmid: 15851598
references.citation: Biomaterials. 2011 Oct;32(30):7514-23
references.pmid: 21783246
references.citation: Circ Res. 2011 Aug 5;109(4):428-36
references.pmid: 21737787
references.citation: Circ Cardiovasc Imaging. 2008 Nov;1(3):197-204
references.pmid: 19808543
references.citation: Biomaterials. 2007 Sep;28(25):3587-93
references.pmid: 17524477
references.citation: J Mol Cell Cardiol. 2001 May;33(5):907-21
references.pmid: 11343414
references.citation: Eur Heart J. 2008 Aug;29(15):1807-18
references.pmid: 18523058
references.citation: J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23
references.pmid: 19729119
references.citation: Eur Heart J. 2005 Jun;26(12):1188-95
references.pmid: 15764613
references.citation: Am Heart J. 2011 Oct;162(4):671-7
references.pmid: 21982659
references.citation: Biomaterials. 2011 Mar;32(9):2407-16
references.pmid: 21186056
references.citation: Circulation. 2008 Mar 18;117(11):1388-96
references.pmid: 18316487
references.citation: Biomaterials. 2005 Jan;26(3):319-26
references.pmid: 15262474
references.citation: Biomaterials. 2009 Oct;30(29):5409-16
references.pmid: 19608268
references.citation: Circulation. 2005 Aug 30;112(9 Suppl):I150-6
references.pmid: 16159808
references.citation: J Orthop Res. 2006 Jun;24(6):1299-309
references.pmid: 16649228
references.citation: Heart Surg Forum. 2003;6(2):E20-6
references.pmid: 12716647
references.citation: Circulation. 2002 Oct 8;106(15):1913-8
references.pmid: 12370212
references.citation: Eur J Heart Fail. 2009 Jan;11(1):14-9
references.pmid: 19147452
references.citation: Circulation. 2005 Aug 30;112(9 Suppl):I173-7
references.pmid: 16159811